Quadrant Capital Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.86K	Buy	308 +280	+1,000%	+$6.69K	﹤0.01%	2294
2025 Q4	$748	Sell	28 -28	-50%	-$669	﹤0.01%	2620
2025 Q3	$1.2K	Buy	+56	New	+$1.32K	﹤0.01%	2546
2025 Q2	–	Sell	-9,258	Closed	-$154K	–	1344
2025 Q1	$154K	Buy	+9,258	New	+$168K	0.01%	1410
2024 Q4	–	Sell	-205	Closed	-$3.15K	–	2734
2024 Q3	$3.15K	Buy	+205	New	+$3.42K	﹤0.01%	2417
2022 Q4	–	Sell	-435	Closed	-$7K	–	2733
2022 Q3	$7K	Buy	435 +369	+559%	+$5.98K	﹤0.01%	1999
2022 Q2	$1K	Sell	66 -44	-40%	-$821	﹤0.01%	2309
2022 Q1	$2K	Sell	110 -79	-42%	-$1.91K	﹤0.01%	2118
2021 Q4	$4K	Buy	189 +47	+33%	+$945	﹤0.01%	1926
2021 Q3	$2K	Sell	142 -418	-75%	-$8.06K	﹤0.01%	2098
2021 Q2	$14K	Buy	560 +427	+321%	+$9.64K	﹤0.01%	1374
2021 Q1	$3K	Buy	133 +27	+25%	+$1.19K	﹤0.01%	1923
2020 Q4	$6K	Buy	106 +65	+159%	+$3.23K	﹤0.01%	1610
2020 Q3	$2K	Buy	+41	New	+$1.77K	﹤0.01%	1781
2020 Q2	–	Sell	-968	Closed	-$41K	–	2199
2020 Q1	$41K	Sell	968 -181	-16%	-$7.46K	0.01%	958
2019 Q4	$48K	Buy	1,149 +181	+19%	+$7.87K	0.01%	1354
2019 Q3	$34K	Hold	968	–	–	0.01%	1376
2019 Q2	$25K	Buy	+968	New	+$24.7K	﹤0.01%	1544
2017 Q1	–	Sell	-2,345	Closed	-$67K	–	2057
2016 Q4	$67K	Sell	2,345 -236	-9%	-$6.24K	0.03%	351
2016 Q3	$81K	Buy	2,581 +2,351	+1,022%	+$79.7K	0.05%	294
2016 Q2	$7K	Buy	+230	New	+$7.7K	﹤0.01%	1111
2016 Q1	–	Sell	-179	Closed	-$6K	–	1791
2015 Q4	$6K	Buy	+179	New	+$6.31K	﹤0.01%	959